Home » Stocks » MEDNAX, Inc.

MEDNAX, Inc. (MD)

Stock Price: $19.92 USD -0.38 (-1.87%)
Updated Aug 13, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.70B
Revenue (ttm) 3.48B
Net Income (ttm) -1.94B
Shares Out 85.51M
EPS (ttm) -23.43
PE Ratio n/a
Forward PE 14.53
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 13, 2020
Last Price $19.92
Previous Close $20.30
Change ($) -0.38
Change (%) -1.87%
Day's Open 20.11
Day's Range 19.82 - 20.33
Day's Volume 375,109
52-Week Range 7.37 - 28.66

More Stats

Market Cap 1.70B
Enterprise Value 3.30B
Earnings Date (est) Oct 29, 2020
Ex-Dividend Date n/a
Shares Outstanding 85.51M
Float 63.03M
EPS (basic) -22.31
EPS (diluted) -23.43
FCF / Share 3.49
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 17.13%
Payout Ratio n/a
Shares Short 4.76M
Short Ratio 6.28
Short % of Float 6.57%
Beta 1.48
PE Ratio n/a
Forward PE 14.53
P/FCF Ratio 5.84
PS Ratio 0.49
PB Ratio 2.10
Revenue 3.48B
Operating Income -1.25B
Net Income -1.94B
Free Cash Flow 291.63M
Net Cash -1.59B
Net Cash / Share -18.66
Gross Margin 25.63%
Operating Margin -35.83%
Profit Margin -61.50%
FCF Margin 8.38%
ROA 4.96%
ROE -67.51%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (12)

Buy 2
Overweight 0
Hold 8
Underweight 1
Sell 1

Analyst Consensus: Overweight

Price Target

$19.73*
(-0.95% downside)
Low
11.0
Current: $19.92
High
25.0
Target: 19.73
*Average 12-month price target from 11 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue3,5143,4553,2533,1832,7802,4392,1541,8171,5881,402
Revenue Growth1.7%6.19%2.21%14.5%13.99%13.23%18.57%14.38%13.32%-
Gross Profit8929209201,034928807710614551489
Operating Income-1,136432455572558513452390355313
Net Income-1,498269320325336317281241218203
Shares Outstanding83.5091.1092.4392.4293.0898.5999.1197.3995.4193.26
Earnings Per Share-13.782.823.293.493.583.182.782.422.232.13
EPS Growth--14.29%-5.73%-2.51%12.58%14.39%14.88%8.52%4.69%-
Operating Cash Flow347290511444369423405325271241
Capital Expenditures-31.88-30.48-26.15-39.26-27.07-18.06-15.65-14.50-31.33-12.11
Free Cash Flow315259485405342405390310239228
Cash & Equivalents18267.4190.4966.9860.4353.9637.5927.8622.7443.63
Total Debt1,8071,9751,8531,7061,27556927.2414429.47147
Net Cash / Debt-1,625-1,907-1,762-1,639-1,214-51510.36-116-6.74-103
Assets4,1465,9375,8675,3394,5473,6083,0092,7502,2732,038
Liabilities2,6472,8502,8012,5792,1091,343666715542590
Book Value1,4993,0883,0662,7612,4382,2652,3432,0351,7311,447
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name MEDNAX, Inc.
Country United States
Employees 9,480
CEO Mark S. Ordan

Stock Information

Ticker Symbol MD
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Care Facilities
Unique Identifier NYSE: MD
IPO Date September 19, 1995

Description

MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patients with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, pediatric ophthalmology, other newborn pediatric care, and newborn hearing screening program, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. Additionally, it offers consulting services to healthcare facilities and physicians. As of March 12, 2020, the company operated a network of approximately 4,325 physicians. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.